Average Co-Inventor Count = 8.11
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (19 from 2,405 patents)
2. Merck + Co., Inc. (2 from 4,770 patents)
3. Cancer Research Technology Limited (1 from 263 patents)
4. Astex Therapeutics Limited (1 from 123 patents)
5. Merck Sharp & Dohme LLC (6 patents)
13 patents:
1. 12162883 - Process for the preparation of intermediates useful for making (2S,5R)-7-oxo-n-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
2. 11603367 - Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them
3. 10526363 - Substituted phosphoramidate compounds and uses thereof
4. 10472345 - Methods of preparing hydroxylamine derivatives useful in the preparation of anti-infective agents
5. 10308633 - Process for making M1 receptor positive allosteric modulators
6. 9527855 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors
7. 9272999 - Crystalline polymorphic forms of an antidiabetic compound
8. 9242917 - Crystal forms of a HCV protease inhibitor
9. 9187488 - Process for preparing chiral dipeptidyl peptidase-IV inhibitors
10. 9012488 - Crystalline polymorphic forms of an antidiabetic compound
11. 8697740 - Crystalline polymorphic forms of an antidiabetic compound
12. 7411088 - Stereoselective synthesis of a 4,4-disubstituted cyclohexanepropanoic acid
13. 7276637 - Synthesis of cyclohexanone derivatives